The German company BioNTech, developer of the Pfizer vaccine, will apply for approval to use this adapted drug to children aged five to 11 years, said medical director Oezlem Tuereci.
“We are already preparing for production. The vaccine is the same, but with fewer high doses, and fewer refills,” Tuereci said, according to the German media Der Spiegel on Sept. 10.
He added: “In the coming weeks, we will present the results of our study in children aged five to 11 years to authorities around the world,” noting that the procedure would take a few weeks.
The multinational pharmaceutical company also expects to apply for another approval in about three months to extend the vaccination to children between 6 months and two years of age, reported Reuters.
The U.S. biotechnology company Moderna also made a similar statement on Sept. 9, saying that it had completed a trial to test its vaccine in children between six and eleven years of age.
Simultaneously, it is working on another study for formulated dosing aimed at infants as young as six months.
So far, in most countries, only those over the age of 12 are allowed to be inoculated with the COVID-19 or CCP (Chinese Communist Party) virus vaccines, and there have been many warnings about extending the treatment to children under that age.
For its part, the French National Ethics Council (CCNE) published a report analyzing this possibility and found little or no benefit to vaccinating children and adolescents against coronavirus.
“The decision to vaccinate children and adolescents must therefore take into account their role in the spread of the virus,” the CCNE said in its report.
It added: “Although controversies persist, more and more publications show that children, especially those under 10-12 years of age, are not the most frequent source of contamination.”
On the other hand, side effects are still unavoidable; in fact, the number of cases of heart inflammation suffered by children under 17 years of age was 397 in the United States, following the application of Pfizer brand vaccines.
This was reported in the Centers for Disease Control and Prevention (CDC) weekly report as of July 30, based on data voluntarily provided by users of the system.
Subjecting children to the controversial treatment has generated many warnings from scientists such as German microbiology and epidemiology specialist Dr. Sucharit Bhakdi, who emphasized the dangers involved.
Earlier, an FDA document revealed that 86% of children between the ages of 12 and 15 who participated in the Pfizer vaccine trials experienced adverse effects, ranging from “mild” to “severe.”
They also suffered other side effects such as diarrhea, chills, joint pain, vomiting, and muscle pain. Also, to be taken into account are the possible medium and long-term adverse effects that could be generated among those who receive these vaccines.
Despite all these conclusive data, the FDA considered that the vaccine did not represent a danger for children and approved its emergency use on May 10.